Yes, Tesamorelin is FDA-approved for human consumption. It was approved in 2010 for the treatment of HIV-associated lipodystrophy, a condition characterized by abnormal fat distribution in individuals living with HIV. The approval is specifically for reducing excess abdominal fat in these patients by medical professionals. However, its use is limited to this indication and is not approved for general weight loss or other conditions. Please note PharmaLabGlobal supplies peptides for laboratory research purposes only. This website is for informational purposes only.
Tesamorelin, like any medication, can cause side effects. One of the most common issues is Tesamorelin injection site reactions, which may include redness, pain, or irritation where the medication is administered. Additionally, some individuals may experience muscle and joint pain, often accompanied by stiffness or discomfort.
Swelling due to fluid retention is another potential side effect, particularly in the hands, feet, or ankles. Nausea, mild cognitive impairment and headaches, are also frequently reported. For some, Tesamorelin can increase blood sugar levels, which may worsen pre-existing diabetes, insulin resistance or, in rare cases, trigger new-onset diabetes.